BRVE

$21.82-0.23%visit website download financials (.py)

Braveheart Bio, Inc.

Market Cap

$1.7B

As of 2026-10-16

Sector

Health Care

Industry

Pharmaceutical Preparations

Beta (raw)

—

Insufficient price history

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Price / TTM revenue

P/B

N/M

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

purchases / sales, 90d

Short Volume

80%

W/W -7.7pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →

Velocity Score

47.00x

Avg Daily Buying (90d)

98,170 sh/day

Baseline Daily Buying

0.0 sh/day

Unique Buyers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-07	2026-08-11	AH Bio Fund IV, L.P.	10% Owner	Purchase	1.10M	$18.00	$19.80M	10.23M	View
2026-08-07	2026-08-11	ORBIMED ADVISORS LLC	Director	Purchase	1.94M	$18.00	$34.92M	11.90M	View
2026-08-07	2026-08-11	Chimovits Erez	Director	Purchase	1.94M	$18.00	$34.92M	11.90M	View
2026-08-07	2026-08-07	Forbion Growth Opportunities Fund III Cooperatief U.A.	10% Owner	Purchase	3.60M	$18.00	$64.80M	11.64M	View
2026-08-07	2026-08-07	Lubner David Charles	Director	Purchase	55.6K	$18.00	$1000K	55.6K	View

1–5 of 10

1 / 2

BRVE

Signals

Factor Profile

Recent News

Braveheart Bio, Inc. (BRVE)

Reporting Insiders

Factor Profile

Date	Insider	Type	Shares	Value
2026-08-07	AH Bio Fund IV, L.P.	P	1,100,000	$20M
2026-08-07	ORBIMED ADVISORS LLC	P	1,666,667	$30M
2026-08-07	ORBIMED ADVISORS LLC	P	273,333	$5M
2026-08-07	Chimovits Erez	P	1,666,667	$30M
2026-08-07	Chimovits Erez	P	273,333	$5M